Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Replication Origin | 1 | 2021 | 16 | 0.90 | Why? |
| Eutheria | 2 | 2021 | 313 | 0.90 | Why? |
| Receptors, Angiotensin | 1 | 2021 | 53 | 0.85 | Why? |
| Angiotensin I | 1 | 2021 | 200 | 0.77 | Why? |
| Host Specificity | 1 | 2021 | 926 | 0.61 | Why? |
| Angiotensin II | 1 | 2021 | 601 | 0.58 | Why? |
| Chiroptera | 3 | 2021 | 3530 | 0.44 | Why? |
| Peptide Fragments | 1 | 2021 | 2075 | 0.42 | Why? |
| Zoonoses | 2 | 2021 | 3034 | 0.40 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.37 | Why? |
| Genetic Predisposition to Disease | 2 | 2021 | 4027 | 0.37 | Why? |
| Communicable Diseases, Emerging | 1 | 2021 | 2523 | 0.32 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.28 | Why? |
| Models, Statistical | 1 | 2021 | 5312 | 0.25 | Why? |
| Ophiophagus hannah | 1 | 2021 | 4 | 0.23 | Why? |
| Genome, Viral | 2 | 2021 | 13157 | 0.23 | Why? |
| Stochastic Processes | 1 | 2021 | 369 | 0.19 | Why? |
| HLA-DR Antigens | 1 | 2021 | 563 | 0.18 | Why? |
| Models, Genetic | 1 | 2021 | 434 | 0.18 | Why? |
| Lipopolysaccharide Receptors | 1 | 2021 | 357 | 0.18 | Why? |
| Amino Acid Sequence | 2 | 2020 | 6049 | 0.18 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.18 | Why? |
| Teicoplanin | 1 | 2020 | 191 | 0.18 | Why? |
| Sequence Homology, Amino Acid | 1 | 2020 | 945 | 0.17 | Why? |
| Muscular Dystrophies | 1 | 2017 | 22 | 0.17 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2021 | 3607 | 0.17 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.16 | Why? |
| Antibodies, Antiphospholipid | 1 | 2021 | 519 | 0.15 | Why? |
| Hand, Foot and Mouth Disease | 1 | 2017 | 115 | 0.15 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.15 | Why? |
| Enterovirus A, Human | 1 | 2017 | 180 | 0.14 | Why? |
| Mosquito Vectors | 1 | 2017 | 351 | 0.14 | Why? |
| Antiphospholipid Syndrome | 1 | 2021 | 533 | 0.14 | Why? |
| Morbidity | 1 | 2021 | 1426 | 0.14 | Why? |
| Chikungunya virus | 1 | 2017 | 339 | 0.14 | Why? |
| Capsid Proteins | 1 | 2017 | 365 | 0.13 | Why? |
| Neuromuscular Diseases | 1 | 2018 | 303 | 0.13 | Why? |
| Amino Acid Substitution | 1 | 2021 | 1706 | 0.13 | Why? |
| Sequence Alignment | 1 | 2020 | 2109 | 0.13 | Why? |
| Chikungunya Fever | 1 | 2017 | 345 | 0.13 | Why? |
| Virus Attachment | 1 | 2020 | 1259 | 0.12 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.11 | Why? |
| Sequence Analysis, RNA | 1 | 2021 | 2290 | 0.11 | Why? |
| Dengue Virus | 1 | 2017 | 910 | 0.10 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.10 | Why? |
| Whole Genome Sequencing | 1 | 2021 | 3239 | 0.10 | Why? |
| Gene Expression | 1 | 2020 | 3332 | 0.10 | Why? |
| Gene Expression Profiling | 1 | 2021 | 3788 | 0.10 | Why? |
| Multiple Organ Failure | 1 | 2020 | 1724 | 0.10 | Why? |
| Phylogeny | 4 | 2021 | 13341 | 0.10 | Why? |
| Pilot Projects | 1 | 2021 | 5182 | 0.10 | Why? |
| Animals | 5 | 2021 | 78931 | 0.09 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.09 | Why? |
| Monocytes | 1 | 2021 | 2978 | 0.09 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.09 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.09 | Why? |
| Drug Evaluation, Preclinical | 1 | 2020 | 3347 | 0.09 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.08 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.08 | Why? |
| Humans | 19 | 2021 | 930598 | 0.08 | Why? |
| Virus Assembly | 1 | 2008 | 438 | 0.07 | Why? |
| Dengue | 1 | 2017 | 1565 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.07 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.07 | Why? |
| Cough | 1 | 2018 | 4891 | 0.07 | Why? |
| France | 4 | 2021 | 12074 | 0.06 | Why? |
| Protein Binding | 1 | 2020 | 11430 | 0.06 | Why? |
| Vietnam | 2 | 2017 | 1665 | 0.06 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.05 | Why? |
| Heart Failure | 1 | 2020 | 6638 | 0.05 | Why? |
| Isoleucine | 1 | 2017 | 19 | 0.04 | Why? |
| Lung Volume Measurements | 1 | 2018 | 115 | 0.04 | Why? |
| Cambodia | 1 | 2017 | 190 | 0.04 | Why? |
| Larva | 1 | 2017 | 153 | 0.04 | Why? |
| Mucociliary Clearance | 1 | 2018 | 72 | 0.04 | Why? |
| Inhalation | 1 | 2018 | 86 | 0.04 | Why? |
| Culex | 1 | 2017 | 66 | 0.04 | Why? |
| Mink | 1 | 2021 | 399 | 0.04 | Why? |
| Respiratory Muscles | 1 | 2018 | 116 | 0.04 | Why? |
| Male | 7 | 2021 | 367725 | 0.04 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.04 | Why? |
| Female | 7 | 2021 | 380317 | 0.04 | Why? |
| Valine | 1 | 2017 | 359 | 0.04 | Why? |
| Molecular Epidemiology | 1 | 2021 | 1638 | 0.04 | Why? |
| Preliminary Data | 1 | 2017 | 457 | 0.04 | Why? |
| Aedes | 1 | 2017 | 380 | 0.03 | Why? |
| China | 1 | 2021 | 50654 | 0.03 | Why? |
| Nigeria | 1 | 2021 | 2292 | 0.03 | Why? |
| Enterovirus | 1 | 2017 | 402 | 0.03 | Why? |
| Selection, Genetic | 1 | 2017 | 691 | 0.03 | Why? |
| HIV-1 | 1 | 2008 | 3365 | 0.03 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.03 | Why? |
| Spatio-Temporal Analysis | 1 | 2017 | 1182 | 0.03 | Why? |
| Turkey | 1 | 2021 | 3937 | 0.03 | Why? |
| Protein Conformation | 1 | 2021 | 4386 | 0.03 | Why? |
| Adult | 4 | 2021 | 244371 | 0.03 | Why? |
| Polymorphism, Genetic | 1 | 2017 | 1074 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3633 | 0.02 | Why? |
| Hospitalization | 2 | 2017 | 54280 | 0.02 | Why? |
| Genotype | 1 | 2021 | 4697 | 0.02 | Why? |
| Antihypertensive Agents | 1 | 2021 | 1962 | 0.02 | Why? |
| Epidemics | 2 | 2021 | 6407 | 0.02 | Why? |
| Hospitals, Teaching | 1 | 2017 | 1609 | 0.02 | Why? |
| Virus Integration | 1 | 2008 | 96 | 0.02 | Why? |
| Viral Core Proteins | 1 | 2008 | 134 | 0.02 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.02 | Why? |
| Capsid | 1 | 2008 | 197 | 0.02 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
| Respiratory Insufficiency | 2 | 2018 | 7301 | 0.02 | Why? |
| Renin-Angiotensin System | 1 | 2021 | 3661 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2017 | 3493 | 0.02 | Why? |
| Infant | 2 | 2017 | 30274 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.02 | Why? |
| Child, Preschool | 2 | 2017 | 36283 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.02 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.01 | Why? |
| Emergency Medical Services | 1 | 2017 | 3557 | 0.01 | Why? |
| Aged | 3 | 2021 | 215776 | 0.01 | Why? |
| DNA, Viral | 1 | 2008 | 2521 | 0.01 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Hospital Mortality | 1 | 2017 | 22087 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2018 | 22116 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2017 | 27595 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |
Devaux's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(131)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(44)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_